Miltenyi Biotec, founded in 1989, has grown to over 1100 employees in 18 countries. The company develops, manufactures, and sells more than 1000 products and services; particularly in the fields of cell biology, immunology, regenerative medicine, and molecular biology.

Miltenyi Biotec developed MACS® Technology, the gold standard method in magnetic cell separation. MACS Technology combines the use of MACS MicroBeads (nano-sized superparamagnetic particles coupled to specific antibodies), patented MACS Columns, and MACS Separators (strong permanent magnets). MACS Technology offers a multitude of applications: from small-scale to large-scale cell purifications, from cell to biomolecule separations, from lab bench to clinical research applications and separation of adult stem cells – for example, with the CliniMACS® Cell Separation System. 

The technical expertise of the employees is vast. It spans biological and chemical disciplines, including immunology, cell and molecular biology, hematology, regenerative medicine, organic and inorganic chemistry through physics and engineering, including biomedical, electrical, plastics and software development.